Clinical Trial Update: Tenofovir Plus Entecavir vs. Tenofovir in Adefovir-Resistant Chronic Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial comparing tenofovir plus entecavir versus tenofovir alone in adefovir-resistant chronic hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis D

Drugs mentioned

• ENTECAVIR (ENTECAVIR)
• TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
• Tenofovir (Tenofovir)

Snippet

Sponsor: Asan Medical Center | Conditions: Chronic Viral Hepatitis B Without Delta-agent | Phase 4 | Status: COMPLETED